AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2025 Issue 4; ICD-10-PCS New/Revised Codes Section X—New Technology

Transfusion of New Therapeutic Substances

In table XW1, Transfusion of Anatomical Regions, 2 new substance values were added for the substances listed below. These substances have the qualifier value New Technology Group 11.Device/Substance/Technology S Mozafancogene Autotemcel Y Nonautologous (Human) Fibrinogen Concentrate,  Shelf-stable Mozafancogene Autotemcel (fanca-cel)Mozafancogene autotemcel is used to treat patients with Fanconi anemia subtype A. Fanconi anemia is caused by defects in the FANCA gene. Mozafancogene autotemcel is a one-time gene therapy infusion that consists of autologous hematopoietic stem cells (HSCs) that are genetically modified with a lentivirus containing a functional copy of the FANCA gene to facilitate the expression of...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.